Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Income Statement [Abstract]
Revenue	$ 9,773	$ 8,333
Operating expenses:
Research and development	86,403	66,001
General and administrative	33,868	28,953
Impairment of long-lived assets	0	4,838
Total operating expenses	120,271	99,792
Loss from operations	(110,498)	(91,459)
Other (expense) income:
Change in fair value of warrant liability	(1,199)	16
Change in fair value of term loan	(6,168)	(4,583)
Interest income	9,224	6,940
Interest expense	(63)	(102)
Other expense	(291)	(110)
Total other income, net	1,503	2,161
Net loss	$ (108,995)	$ (89,298)
Net loss per common share, basic	$ (0.34)	$ (0.36)
Net loss per common share, diluted	$ (0.34)	$ (0.36)
Weighted average common shares outstanding, basic	319,711,972	250,134,421
Weighted average common shares outstanding, diluted	319,711,972	250,134,421